Dr. Daniel Carlat is directs Pew's prescription project, which seeks to ensure transparency in physician-industry relationships and promotes policies to reduce or manage conflicts of interest that could affect patient care.
Before joining Pew, Carlat was a practicing psychiatrist and was president and CEO of Carlat Publishing LLC, which publishes non-industry supported continuing medical education newsletters for psychiatrists and other mental health practitioners.
Carlat is the author of numerous peer-reviewed articles and professional books in psychiatry, most notably The Psychiatric Interview: A Practical Guide, currently in its third edition and translated into several languages. In addition to his professional writing, Dr. Carlat has written about conflicts of interest for the New York Times, the New York Times Magazine, and Wired. His article for The New York Times Magazine, "Dr. Drug Rep", was selected for Harper Perennial’s Best Science Writing 2008 anthology.
In 2010, he published his first book for a general audience, Unhinged: A Doctor’s Alarming Revelations about a Profession in Crisis. The book, which proposes solutions for reforming the mental health care system in the U.S., has garnered significant media attention, including a July 2010 interview on NPR’s Fresh Air.
Dr. Carlat received his M.D. at the University of California, San Francisco, and completed his psychiatric residency at Massachusetts General Hospital in Boston. He is associate clinical professor of psychiatry at Tufts School of Medicine.
Recent WorkView All
Catch a preview of the Our Ocean conference, which will be hosted by the Chilean government in Valparaíso, Chile, on Oct. 5 and 6, and hear the latest in global initiatives to stop illegal fishing. Read More
The U.S. Food and Drug Administration (FDA) has approved two new drugs to treat patients with high cholesterol. These new therapies belong to a class of drugs known as PCSK9 inhibitors and have the potential to reduce the risk of heart attack and stroke for millions of Americans. However, the prices of these drugs—which are administered by injection every two to four weeks—have been... Read More
Members of the Northern Committee of the Western and Central Pacific Fisheries Commission (WCPFC) meet in Sapporo, Japan, Aug. 31 to Sept. 3, to determine what they will do about the dismal status of Pacific bluefin tuna. Read More